\-\ Texto\\:\\ \ \(0\)\
\-\ afebrile\\,\\ mildly\\ elevated\\ wbc\ \(0\)\
\-\ 12cm\\ heterogeneous\\ round\\ soft\\ tissue\\ density\\ mass\\ with\\ rim\\ enhancement\\,\\ containing\\ at\\ least\\ 3\\ 1cm\\ round\\ calcific\\ density\\ structures\\ in\\ the\\ region\\ of\\ the\\ gall\\ bladder\\.\\ no\\ separate\\ gallbladder\\ was\\ identified\\.\ \(0\)\
\-\ complicated\\ cholecystitis\\:\\ \\ gangrenous\\ cholecystitis\\ with\\ focal\\ perforation\\ and\\ pericholecystic\\ abscess\ \(0\)\
\-\ liver\\ abscess\\ incorporating\\ the\\ gallbladder\ \(0\)\
\-\ sequela\\ of\\ perforated\\ cholecystitis\\ with\\ abscess\\/necrotic\\ tissue\\.\ \(0\)\
\-\ perforated\\ gastric\\ ulcer\\ with\\ abscess\\ formation\ \(0\)\
\-\ gallbladder\\ carcinoma\ \(10\)\
\-\ 56y\\/o\\ diabetic\\ female\\ with\\ ruq\\ pain\\ referred\\ to\\ our\\ hospital\\ for\\ liver\\ biopsy\\ secondary\\ to\\ ct\\ findings\\ of\\ a\\ \\"liver\\ mass\\"\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cholecystitis\\:\\ 0\\.33322663965434657\ \(0\)\
\-\ gallbladder\\:\\ 0\\.30892268842120507\ \(0\)\
\-\ abscess\\:\\ 0\\.2959979526705972\ \(0\)\
\-\ perforated\\:\\ 0\\.25180674147415394\ \(0\)\
\-\ liver\\:\\ 0\\.23849559907673062\ \(0\)\
\-\ round\\:\\ 0\\.1888507067070199\ \(0\)\
\-\ incorporating\\:\\ 0\\.17610406059129116\ \(0\)\
\-\ 12cm\\:\\ 0\\.1657842368222776\ \(0\)\
\-\ gangrenous\\:\\ 0\\.16210093228963784\ \(0\)\
\-\ density\\:\\ 0\\.15283323075606903\ \(0\)\
\-\ sequela\\:\\ 0\\.14228598063558556\ \(0\)\
\-\ gall\\:\\ 0\\.13171519408947593\ \(0\)\
\-\ pericholecystic\\:\\ 0\\.12892424727627397\ \(0\)\
\-\ 1cm\\:\\ 0\\.12231381228336602\ \(0\)\
\-\ diabetic\\:\\ 0\\.12231381228336602\ \(0\)\
\-\ calcific\\:\\ 0\\.12139537032046238\ \(0\)\
\-\ tissue\\:\\ 0\\.12090560873930518\ \(0\)\
\-\ ruq\\:\\ 0\\.11697735777538834\ \(0\)\
\-\ separate\\:\\ 0\\.1155835469680634\ \(0\)\
\-\ ulcer\\:\\ 0\\.11427972403227897\ \(0\)\
\-\ with\\:\\ 0\\.11282809273306697\ \(0\)\
\-\ complicated\\:\\ 0\\.10927287743709861\ \(0\)\
\-\ perforation\\:\\ 0\\.10878605282613403\ \(0\)\
\-\ least\\:\\ 0\\.10651374518757044\ \(0\)\
\-\ containing\\:\\ 0\\.10352274037310875\ \(0\)\
\-\ our\\:\\ 0\\.10209189519472006\ \(0\)\
\-\ afebrile\\:\\ 0\\.09950246869347464\ \(0\)\
\-\ gastric\\:\\ 0\\.09707241824979555\ \(0\)\
\-\ mildly\\:\\ 0\\.09305518472999237\ \(0\)\
\-\ rim\\:\\ 0\\.09177207142570651\ \(0\)\
\-\ formation\\:\\ 0\\.0913618594891616\ \(0\)\
\-\ bladder\\:\\ 0\\.08942715312856975\ \(0\)\
\-\ mass\\:\\ 0\\.08803793229886746\ \(0\)\
\-\ structures\\:\\ 0\\.08659161957522643\ \(0\)\
\-\ referred\\:\\ 0\\.08527277079735271\ \(0\)\
\-\ hospital\\:\\ 0\\.08512312386303628\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.08340883144923475\ \(0\)\
\-\ identified\\:\\ 0\\.08170243343935586\ \(0\)\
\-\ wbc\\:\\ 0\\.08145224765669297\ \(0\)\
\-\ biopsy\\:\\ 0\\.08077979622282742\ \(0\)\
\-\ elevated\\:\\ 0\\.0785612895315277\ \(0\)\
\-\ the\\:\\ 0\\.06898423515269934\ \(0\)\
\-\ region\\:\\ 0\\.06893192697482779\ \(0\)\
\-\ focal\\:\\ 0\\.06893192697482779\ \(0\)\
\-\ carcinoma\\:\\ 0\\.06893192697482779\ \(0\)\
\-\ secondary\\:\\ 0\\.06830621659922025\ \(0\)\
\-\ of\\:\\ 0\\.06765643093847608\ \(0\)\
\-\ enhancement\\:\\ 0\\.06633068416376309\ \(0\)\
\-\ soft\\:\\ 0\\.061351828957963615\ \(0\)\
\-\ to\\:\\ 0\\.05762002178361265\ \(0\)\
\-\ findings\\:\\ 0\\.05687603069010154\ \(0\)\
\-\ female\\:\\ 0\\.055609073172864155\ \(0\)\
\-\ ct\\:\\ 0\\.04387331127365888\ \(0\)\
\-\ at\\:\\ 0\\.04352796536403409\ \(0\)\
\-\ pain\\:\\ 0\\.04123745258432888\ \(0\)\
\-\ was\\:\\ 0\\.04016261167887986\ \(0\)\
\-\ no\\:\\ 0\\.03747504533208076\ \(0\)\
\-\ for\\:\\ 0\\.03492864721623926\ \(0\)\
\-\ in\\:\\ 0\\.028668208077864438\ \(0\)\
\-\ and\\:\\ 0\\.023813131229082563\ \(0\)\
